For the past 20 years, there have been constant debate over what adjuvant treatments should be used in which patients with melanoma, says Atkins. But none of the available treatments were effective of tolerable enough to justify their widespread use, Atkins add.

For the past 20 years, there have been constant debate over what adjuvant treatments should be used in which patients with melanoma, says Atkins. But none of the available treatments were effective of tolerable enough to justify their widespread use, Atkins add.